Private Health Funding Under South Africa’...

By João L. Carapinha

June 30, 2025

The article by Solanki et al. critically examines the implications of South Africa’s newly enacted National Health Insurance (NHI) Act. It focu...
Impending Net Drug Price Transparency Regulation in the U.S.
Transparency in Industry Partnerships: Building Trust
Canada Launches Consultation for Essential Prescription Drugs List
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Quantifying EU Medicine Access Challenges
US Argentina WHO Withdrawal: A Shift in Global Health Governance
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
EU Establishes Expert Panel for Orphan Paediatric Devices
The Impact of MFN Pricing on the U.S. Biosimilar Market
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...